Dr Sangeeta Sule received her undergraduate education at Tulane University and her MD degree from Baylor College of Medicine. She continued at Baylor for her internship and residency in Internal Medicine and Pediatrics. Sangeeta then completed her fellowship training in Rheumatology at Johns Hopkins University and joined then joined the faculty where she was Associate Professor. In 2008, she obtained a PhD in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. In 2018, Sangeeta became Chief of Rheumatology at Children’s National Medical Center and Associate Professor of Pediatrics at George Washington University School of Medicine and Health Sciences. Sangeeta’s research interests focus on clinical outcomes in pediatric lupus and arthritis and her work has been published in multiple peer-reviewed journals. She has also completed advance training in quality improvement and has been involved in projects for development and implementation of outcome measures in pediatric rheumatology.
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences